Metastatic Colorectal Cancers Recruiting Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03775850A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsTreatment
NCT03593226Study to Evaluate Safety & Tolerability of AGI-134 in Solid TumourTreatment
NCT02842125Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerTreatment
NCT02851004Special Combination of BBI608 and PembrolizumabTreatment